A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
Status:
COMPLETED
Trial end date:
2025-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).